论文部分内容阅读
1981年6月—1994年11月共收治经确诊为溃结的患者97例,按照1978年全国消化系统疾病学术会议拟定的诊断标准,以及1993年全国慢性非感染性肠道疾病学术研讨会关于溃结诊断及治疗标准修订后的标准,选其主要用药如激素、柳氮磺胺吡啶(SASP)及中药等治疗效果作一初步报告。 1 对象和方法 1.1 对象 男53例,女44例,男女之比1.2:1,发病年龄14—69岁,平均年龄37.5±1.6岁,其中轻型50例,中度36例,重症型9例,暴发型2例(并发中毒性巨结肠)。 1.2 方法 给药方法轻型选用口服SASP 0.5g,4次/d,为避免副作用,从小剂量开始,首剂0.5g,以后每天增加0.5g
From June 1981 to November 1994, 97 cases of patients with clinically proven ulceration were admitted. According to the diagnostic criteria formulated by the National Conference on Digestive Diseases in 1978 and the National Symposium on Chronic Non-Infectious Intestinal Diseases in 1993 Ulcerative colitis diagnosis and treatment standards revised standards, the election of its main drugs such as hormones, sulfasalazine (SASP) and traditional Chinese medicine and other treatment for a preliminary report. 1 Subjects and methods 1.1 Object 53 males and 44 females, the ratio of men and women 1.2: 1, the age of onset 14-69 years old, average age 37.5 ± 1.6 years, of which 50 cases of light, 36 cases of moderate, severe 9 cases, Outbreak in 2 cases (complicated with toxic megacolon). 1.2 Methods of administration Light oral SASP 0.5g, 4 times / d, in order to avoid side effects, starting from a small dose, the first dose of 0.5g, 0.5g